BCMACD3 Bispecific Antibodies for Multiple Myeloma (MM)
Currently, BCMA/CD3 bispecific antibodies have shown therapeutic potential in R/R MM. Here, we will explore the BCMA/CD3 bispecific antibodies under investigation for treating MM.
Like this book? You can publish your book online for free in a few
minutes!